Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4456 to 4470 of 7685 results

  1. Renin–angiotensin–aldosterone system antagonists: For people aged over 75 years with CKD, what is the clinical effectiveness of renin–angiotensin–aldosterone system (RAAS) antagonists? [2014]

    Recommendation ID NG203/20 Question Renin–angiotensin–aldosterone system antagonists: For people aged over 75 years with CKD, what is the

  2. Multicomponent intervention: For people in long-term care, is a multicomponent non-pharmacological intervention more clinically and cost effective than usual care in preventing the development of delirium?

    Recommendation ID CG103/04 Question Multicomponent intervention: For people in long-term care, is a multicomponent non-pharmacological

  3. Further research on incisionless otoplasty should describe the precise surgical techniques used and should report both short- and long-term outcomes, including the need for further procedures.

    Recommendation ID IPG422/1 Question Further research on incisionless otoplasty should describe the precise surgical techniques used and

  4. Further research on laparoscopic mesh pectopexy for apical prolapse of the uterus or vagina should include details of patient selection and long-term outcomes.

    Recommendation ID IPG608/1 Question Further research on laparoscopic mesh pectopexy for apical prolapse of the uterus or vagina should

  5. Further research on percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions should report details of patient selection and subsequent management.

    Recommendation ID IPG633/1 Question Further research on percutaneous insertion of a temporary heart pump for left ventricular haemodynamic

  6. Further research on platelet-rich plasma injections for knee osteoarthritis should be in the form of randomised controlled trials with medium- to long-term follow-up, including validated measures of knee function and patient-reported outcomes.

    Recommendation ID IPG637/1 Question Further research on platelet-rich plasma injections for knee osteoarthritis should be in the form of

  7. Further research on subcutaneous automated low-flow pump implantation for refractory ascites should report details of patient selection, the frequency of pump-related complications, and the need for regular albumin infusions.

    Recommendation ID IPG631/1 Question Further research on subcutaneous automated low-flow pump implantation for refractory ascites should

  8. Further research on the clinical effectiveness of rivaroxaban compared with low molecular weight heparin (LMWH) in patients with active cancer should be conducted.

    Recommendation ID TA261/1 Question Further research on the clinical effectiveness of rivaroxaban compared with low molecular weight heparin

  9. Further research on the safety and efficacy of total distal radioulnar joint replacement for symptomatic joint instability or arthritis should provide information on patient selection, and continue to collect long-term outcomes. NICE may update the guidance on publication of further evidence.

    Recommendation ID IPG595/1 Question Further research on the safety and efficacy of total distal radioulnar joint replacement for symptomatic

  10. Further research on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor, which could include randomised controlled trials, should address patient selection, report on functional improvement and quality of life, and provide long-term follow-up data.

    Recommendation ID IPG617/1 Question Further research on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant